MediVet Biologics relaunches as Ardent Animal Health

September 18, 2020
dvm360 Staff

Under new ownership and leadership, the company reasserts its mission of providing affordable, innovative therapies for canine joint disease and cancer.

Established in 2016, Kentucky-based MediVet Biologics, which develops regenerative medicine and oncology solutions for animals, has announced its relaunch with a new look and new name—Ardent Animal Health.

The company’s core mission is to “develop affordable, innovative treatments for animal cancer and disease while supporting its veterinary partners in their efforts to make a positive impact on pet health,” according to a press release announcing the relaunch. Among the company’s products is an in-clinic adipose regenerative stem cell therapy kit (ActiStem Therapy) for pets suffering from orthopedic disease or injury.

“The name ‘Ardent’ captures the spirit of our organization as a company with fiery passion for innovation guided by compassion for the well-being of animals,” says company President Thomas Masterson. The company’s aim, he says, is to facilitate connections between pet owners seeking advanced care with Ardent’s expanding global network of progressive veterinarians.

“We will continue to focus much of our strategy in creating novel products and services utilized in veterinary hospitals,” say Masterson, “We believe that this approach is key to the future of animal health. It is important not only for value creation, but to ensure veterinarians have the ability to diagnose and treat their patients with the same leading-edge strategies underway in human health. Our animal family members deserve it.”

To learn more about Ardent Animal Health and its’ recent rebranding, go here.